TIL logo

Instil Bio (TIL)

Profile

Full Name

Instil Bio, Inc.

Ticker Symbol

TIL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 19, 2021

Indexes

Not included

Website

http://instilbio.com

Employees

14

Key Details

Price

$16.48(-1.90%)

Market cap

$107.55M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$11.39(+52.54% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$16.48
TIL price is $16.48

30-Day Relative Volume

0.80
TIL 30-day relative volume is 0.80

Price Performance

Price Most recent change

-1.9%
TIL price was down -1.9% on Apr 15, 2025

Price YTD change

-13.67%
TIL price is down -13.67% since January 1st

Price 1-year change

+57.85%
TIL price is up +57.85% year-on-year

Price 3-year change

-91.06%
TIL price is down -91.06% over the past 3 years

Price Range

Price All-time high

$589.80
TIL price is currently -97.21% below its historical high of $589.80

Price 3-year low

$6.08
TIL price is currently +171.05% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$107.55M
TIL market capitalization is $107.55 million

Market cap 3-year change

-90.97%
TIL market capitalization is down -90.97% over the past 3 years

Market cap All-time high

$3.47B
TIL market capitalization is currently -96.90% below its historical high of $3.47 billion

Market cap sector rank

49.18%
TIL market capitalization is higher than 49.18% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.34%
TIL shares outstanding is up +0.34% year-on-year

Shares Outstanding 3-Year Change

+1.01%
TIL shares outstanding is up +1.01% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

2.04
TIL beta is 2.04

200-day SMA

$24.42
TIL price is currently -32.52% below its 200-day simple moving average

50-day SMA

$19.11
TIL price is currently -13.78% below its 50-day simple moving average

RSI

47.26
TIL 14-day relative strength index is 47.26

Volume

0.80
TIL 30-day relative volume is 0.80

ATR

$1.98
TIL average true range is $1.98

10-day Historical Volatility

136.36%
TIL 10-day historical volatility is 136.36%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
TIL annual revenue value is unknown

Revenue Analysts estimate

-
TIL annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
TIL annual revenue 1-year change is unknown

Revenue Sector rank

-
TIL annual revenue is unknown

EPS

EPS

-$11.39
TIL annual earnings per share is -$11.39

EPS Analysts estimate

-$11.51
TIL annual earnings per share is currently -1.04% lower than the consensus analysts' forecast

EPS 1-year change

+52.54%
TIL annual earnings per share is up +52.54% year-on-year

EPS Sector rank

10.92%
TIL annual earnings per share is higher than 10.92% of companies in Healthcare sector

Profit

Gross profit

-
TIL annual gross profit value is unknown

Gross margin

-
TIL annual gross profit margin value is unknown

Operating profit

-$56.05M
TIL annual operating income is -$56.05 million

Operating margin

-
TIL annual operating profit margin value is unknown

Net income

-$74.14M
TIL annual net profit is -$74.14 million

Net margin

-
TIL annual net profit margin value is unknown

Expenses

Total expenses

$56.05M
TIL annual total expenses is $56.05 million

Operating expenses

$56.05M
TIL annual total operating expenses is $56.05 million

Cost of goods sold

-
TIL annual cost of goods sold value is unknown

Selling, general & administrative expenses

$44.21M
TIL annual SGA is $44.21 million

Depreciation and amortization

$3.61M
TIL annual depreciation & amortization is $3.61 million

Interest expense

$8.00M
TIL annual interest expense is $8.00 million

Income tax

-
TIL annual income tax value is unknown

EBIT & EBITDA

EBIT

-$66.14M
TIL annual earnings before interest & taxes is -$66.14 million

EBITDA

-$62.53M
TIL annual EBITDA is -$62.53 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$263.57M
TIL annual total assets is $263.57 million

Non current assets

$139.10M
TIL annual long term assets is $139.10 million

Current assets

$124.47M
TIL annual total current assets is $124.47 million

Cash and cash equivalents

$8.80M
TIL annual cash & cash equivalents is $8.80 million

Accounts receivable

-
TIL annual accounts receivable value is unknown

Inventory

-
TIL annual inventory value is unknown

Liabilities

Total liabilities

$94.13M
TIL annual total liabilities is $94.13 million

Long term liabilities

$86.23M
TIL annual total long term liabilities is $86.23 million

Current liabilities

$7.90M
TIL annual total current liabilities is $7.90 million

Accounts payable

$659.00K
TIL annual accounts payable is $659.00 thousand

Debt

Total debt

$86.89M
TIL annual total debt is $86.89 million

Total debt 1-year change

+0.97%
TIL annual total debt is up +0.97% year-on-year

Long term debt

$85.20M
TIL annual long term debt is $85.20 million

Short term debt

$1.68M
TIL annual short term debt is $1.68 million

Equity & Capital

Shareholders equity

$169.44M
TIL annual stockholders equity is $169.44 million

Book value

$169.44M
TIL annual book value is $169.44 million

Retained earnings

-$655.12M
TIL annual retained earnings is -$655.12 million

Working capital

$116.57M
TIL annual working capital is $116.57 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$55.70M
TIL annual cash flow from operations is -$55.70 million

Cash from operations 1-year change

+32.1%
TIL annual cash flow from operations is up +32.1% year-on-year

Cash from investing

$53.97M
TIL annual cash flow from investing activities is $53.97 million

Cash from investing 1-year change

+31.23%
TIL annual cash flow from investing activities is up +31.23% year-on-year

Cash from financing

$1.75M
TIL annual cash flow from financing activities is $1.75 million

Cash from financing 1-year change

-78.29%
TIL annual cash flow from financing activities is down -78.29% year-on-year

CAPEX

CAPEX

-
TIL annual capital expenditures value is unknown

CAPEX 1-year change

-
TIL annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$65.70M
TIL annual free cash flow is -$65.70 million

Free cash flow 1-year change

+36.03%
TIL annual free cash flow is up +36.03% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
TIL annual gross profit margin value is unknown

Operating margin

-
TIL annual operating profit margin value is unknown

Net margin

-
TIL annual net profit margin value is unknown

ROA & ROE

ROA

-28.13%
TIL annual return on assets is -28.13%

ROE

-43.75%
TIL annual return on equity is -43.75%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TIL price to earnings ratio value is unknown

PE ratio Sector rank

-
TIL price to earnings ratio is unknown

PB Ratio

PB ratio

0.63
TIL price to book ratio is 0.63

PB ratio Sector rank

34.24%
TIL price to book ratio is higher than 34.24% of companies in Healthcare sector

PS Ratio

PS ratio

-
TIL price to sales ratio value is unknown

PS ratio Sector rank

-
TIL price to sales ratio is unknown

Enterprise value

Enterprise value

$185.63M
TIL enterprise value is $185.63 million

Enterprise value Sector rank

58.02%
TIL enterprise value is higher than 58.02% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.96
TIL EV/EBITDA is -2.96

EV/EBITDA Sector rank

26.17%
TIL EV/EBITDA is higher than 26.17% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

15.76
TIL annual current ratio is 15.76

Quick ratio

-
TIL annual quick ratio value is unknown

Leverage

Debt to equity

0.51
TIL annual debt to equity ratio is 0.51

Interest coverage ratio

-8.27
TIL annual interest coverage ratio is -8.27

Risk & Stability

Piotroski F-Score

-
TIL piotroski f-score value is unknown

Altman Z-Score

-
TIL altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 5, 25 HC Wainwright & Co.
Buy
Feb 13, 25 JMP Securities
Market Perform
Jan 7, 25 Jefferies
Buy
Nov 18, 24 HC Wainwright & Co.
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Nov 4, 24 JMP Securities
Market Perform
Sep 17, 24 HC Wainwright & Co.
Buy
Sep 16, 24 HC Wainwright & Co.
Buy
Sep 16, 24 Baird
Outperform
Sep 13, 24 Baird
Outperform

Institutional Ownership

Similar stocks

OBIO logo
Orchestra BioMed Holdings (OBIO)
ALEC logo
Alector (ALEC)
BTMD logo
biote (BTMD)
Contineum Therapeutics Class A (CTNM)
Neumora Therapeutics (NMRA)
TNXP logo
Tonix Pharmaceuticals Holding (TNXP)
INFU logo
InfuSystem Holdings (INFU)
ENTA logo
Enanta Pharmaceuticals (ENTA)
KRMD logo
KORU Medical Systems (KRMD)
  • What is the ticker symbol for Instil Bio?
  • Does Instil Bio pay dividends?
  • What sector is Instil Bio in?
  • What industry is Instil Bio in?
  • What country is Instil Bio based in?
  • When did Instil Bio go public?
  • Is Instil Bio in the S&P 500?
  • Is Instil Bio in the NASDAQ 100?
  • Is Instil Bio in the Dow Jones?
  • When was Instil Bio's last earnings report?
  • When does Instil Bio report earnings?
  • Should I buy Instil Bio stock now?

What is the ticker symbol for Instil Bio?

The ticker symbol for Instil Bio is NASDAQ:TIL

Does Instil Bio pay dividends?

No, Instil Bio does not pay dividends

What sector is Instil Bio in?

Instil Bio is in the Healthcare sector

What industry is Instil Bio in?

Instil Bio is in the Biotechnology industry

What country is Instil Bio based in?

Instil Bio is headquartered in United States

When did Instil Bio go public?

Instil Bio's initial public offering (IPO) was on March 19, 2021

Is Instil Bio in the S&P 500?

No, Instil Bio is not included in the S&P 500 index

Is Instil Bio in the NASDAQ 100?

No, Instil Bio is not included in the NASDAQ 100 index

Is Instil Bio in the Dow Jones?

No, Instil Bio is not included in the Dow Jones index

When was Instil Bio's last earnings report?

Instil Bio's most recent earnings report was on Mar 4, 2025

When does Instil Bio report earnings?

The next expected earnings date for Instil Bio is May 9, 2025

Should I buy Instil Bio stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page